Get ready for a thrilling update on the box office journey of Shahid Kapoor and Triptii Dimri's latest film, O Romeo! The movie is on fire, and its success is a testament to the power of word-of-mouth.
After an impressive first week, O Romeo has entered its second weekend with a bang. Directed by the talented Vishal Bhardwaj, this romantic action drama is captivating audiences and creating quite a buzz on BookMyShow.
But here's where it gets controversial... The morning trends on the second Saturday were nothing short of brilliant! Between 8 AM and 12 PM, O Romeo recorded a staggering 8K ticket sales on BMS. Compare that to the 5.4K tickets sold during the same window on the previous Friday, and you'll see a massive 48.7% jump in just four hours! The film's momentum is undeniable.
In the 11 AM to 12 PM slot alone, O Romeo shifted to 3.1K ticket sales, a significant leap from the 1.9K tickets sold during the same hour on the previous day. This dramatic increase in ticket sales is a clear indication of the film's growing popularity and the positive word-of-mouth it's generating.
With a 48% jump in morning trends, O Romeo is eyeing an even bigger second Saturday total at the box office. If the night shows maintain the same grip, we might witness Shahid Kapoor's romantic saga reaching the 1 million tickets milestone on BMS sooner than anyone anticipated.
Currently, O Romeo has crossed the 830K mark on BMS, proving its strong theatrical pull. The film has been a consistent performer since its release, and its journey on BMS is a testament to its enduring appeal.
And this is the part most people miss... Here's a breakdown of O Romeo's ticket sales on BMS after eight days:
- Pre-Sales: 63K
- Week 1: 729K
- Day 8, 2nd Friday: 41.1K
- Total: 833.1K
These numbers speak for themselves and showcase the film's steady performance and growing fan base.
So, what do you think? Is O Romeo's box office success a sign of a well-deserved triumph, or is there more to the story? Feel free to share your thoughts and opinions in the comments below! We'd love to hear your take on this exciting development.
